Replimune REPL
NASDAQ REPL
$13.24 +0.24 (+1.85%)
At close: Sep 30, 2026 · 4:00 PM EDT

Replimune (REPL) Long-Term Debt Issuances (2023)

Updated

Replimune's Long-Term Debt Issuances came in at $35 million for FY2026 (year ended Mar 31, 2026).

Analysis

Replimune (REPL) Long-Term Debt Issuances (2023) Analysis & Trends

Going back to FY2020, Replimune's Long-Term Debt Issuances data covers 4 fiscal years.

  • Long-Term Debt Issuances carries a three-year compound annual growth rate of 7.5% (FY2023 to FY2026).
  • Per Business Quant, earlier fiscal years put Long-Term Debt Issuances at $15 million in FY2024 (-46.7%) and $28.15 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Replimune 1.11 Bn 1.11 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -1.85 Mn
API Access

Replimune Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=REPL&period=max&api_key=YOUR_API_KEY